Search research articles
Contact Us
Filters
Showing results (81-90 of 87) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 87 results.
Cell Research
|
July 15, 2020
Geng et al. reply
Xinyi Wang, Guangqiang Sun, Teng Feng, et al.
Frontiers in Immunology
|
February 11, 2026
Correction: RBM39 shapes innate immunity by controlling expression of key factors of the interferon response
Teng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Frontiers in Immunology
|
May 7, 2025
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response
Teng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Biochemical and Biophysical Research Communications
|
July 21, 2024
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects
Anne Dropmann, Sophie Alex, Katharina Schorn, et al.
The American Journal of Pathology
|
May 13, 2016
Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression
Zhe Shen, Yan Liu, Bedair Dewidar, et al.
Gastroenterology
|
April 18, 2024
Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells
Cong Si Tran, Julia Kersten, Jingyi Yan, et al.
Alzheimer'S Research & Therapy
|
March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia
Shifu Xiao, Piu Chan, Tao Wang, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 87) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 87 results.
Cell Research
|
July 15, 2020
Geng et al. reply
Xinyi Wang, Guangqiang Sun, Teng Feng, et al.
Frontiers in Immunology
|
February 11, 2026
Correction: RBM39 shapes innate immunity by controlling expression of key factors of the interferon response
Teng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Frontiers in Immunology
|
May 7, 2025
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response
Teng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Biochemical and Biophysical Research Communications
|
July 21, 2024
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects
Anne Dropmann, Sophie Alex, Katharina Schorn, et al.
The American Journal of Pathology
|
May 13, 2016
Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression
Zhe Shen, Yan Liu, Bedair Dewidar, et al.
Gastroenterology
|
April 18, 2024
Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells
Cong Si Tran, Julia Kersten, Jingyi Yan, et al.
Alzheimer'S Research & Therapy
|
March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia
Shifu Xiao, Piu Chan, Tao Wang, et al.
Page
of 9